AIIMS Delhi, Liverpool University Join Hands For Head And Neck Cancer Research
The All India Institute Of Medical Science (AIIMS) in New Delhi and the University of Liverpool in the UK have entered into a collaborative agreement for joint research on head and neck cancer. The initiative seeks to leverage the pre-existing collaboration.
The All India Institute Of Medical Science (AIIMS) in New Delhi and the University of Liverpool in the UK have entered into a collaborative agreement for joint research on head and neck cancer.
¡°AIIMS Liverpool Collaborative Centre for Translational Research in Head and Neck Cancer ¨C ALHNS¡± will build upon the pre-existing collaboration and links between the Liverpool Head and Neck Centre (LNHC), University of Liverpool and the Head and Neck Cancer Unit at AIIMS New Delhi.
One Nation, One AIIMS, One Card! ?
¡ª Dr Mansukh Mandaviya (@mansukhmandviya) February 12, 2024
With the launch of AIIMS-SBI digital patient care card today, now patients can avail all the services at @aiims_newdelhi cashless with just one card.
This will further strengthen the digital healthcare ecosystem in India. pic.twitter.com/u0KSEF4Uyj
Head and Neck Cancer research
This initiative seeks to leverage the strengths of two leading centres of head-neck oncology that enjoy global reputations and leadership positions in their respective geographies.
The initiative will impact the care of patients with head and neck cancer by combining resources at both institutions to develop joint research and education programmes which will enhance the quality of research outputs and education.
ALHNS also aims to have commonly articulated strategic goals in order to deliver cutting-edge medical innovation and personalized cancer treatments.
Head and Neck Cancer in India
Head and Neck Cancer (HNC) is the seventh-most common cancer and developing countries and includes a group of cancers of the mouth, sinuses, nose, or throat.
A recent study found that HNC had a prevalence rate of 25.9 and 8.0 per 100,000 population, respectively, in males and females. The risk of developing HNC was 1 in 33 for males and 1 in 107 for females.
Head and Neck Cancer causes
Alcohol and tobacco consumption are major risk factors for HNC. All tobacco products, including cigarettes, cigars, pipes, and smokeless tobacco are linked to head and neck cancers.
While HNC is a growing health crisis in India, it should be noted that it has a survival rate 70 to 90 per cent in people with Stage I or Stage II cancer.
Early identification and treatment are the keys to reducing mortality from HNC.
For more news and current affairs from around the world, please visit Indiatimes News.